
### [NCIT:C26893](http://purl.obolibrary.org/obo/NCIT_C26893)
**Label:** Thyroid Gland Disorder

**Subclasses:** [NCIT:C46095](http://purl.obolibrary.org/obo/NCIT_C46095) (Solid Variant Thyroid Gland Papillary Carcinoma), [NCIT:C118829](http://purl.obolibrary.org/obo/NCIT_C118829) (Familial Nonmedullary Thyroid Gland Carcinoma), [NCIT:C46099](http://purl.obolibrary.org/obo/NCIT_C46099) (Hereditary Thyroid Gland Medullary Carcinoma), [NCIT:C46098](http://purl.obolibrary.org/obo/NCIT_C46098) (Sporadic Thyroid Gland Medullary Carcinoma), [NCIT:C7427](http://purl.obolibrary.org/obo/NCIT_C7427) (Thyroid Gland Diffuse Sclerosing Papillary Carcinoma), [NCIT:C3502](http://purl.obolibrary.org/obo/NCIT_C3502) (Thyroid Gland Follicular Adenoma), [NCIT:C6134](http://purl.obolibrary.org/obo/NCIT_C6134) (Stage II Thyroid Gland Medullary Carcinoma), [NCIT:C6133](http://purl.obolibrary.org/obo/NCIT_C6133) (Stage I Thyroid Gland Medullary Carcinoma), [NCIT:C6136](http://purl.obolibrary.org/obo/NCIT_C6136) (Stage IV Thyroid Gland Medullary Carcinoma), [NCIT:C4035](http://purl.obolibrary.org/obo/NCIT_C4035) (Thyroid Gland Papillary Carcinoma), [NCIT:C6135](http://purl.obolibrary.org/obo/NCIT_C6135) (Stage III Thyroid Gland Medullary Carcinoma), [NCIT:C7263](http://purl.obolibrary.org/obo/NCIT_C7263) (Thyroid Gland Immunoblastic Lymphoma), [NCIT:C9121](http://purl.obolibrary.org/obo/NCIT_C9121) (Stage III Thyroid Gland Follicular Carcinoma), [NCIT:C9122](http://purl.obolibrary.org/obo/NCIT_C9122) (Stage III Thyroid Gland Papillary Carcinoma), [NCIT:C65200](http://purl.obolibrary.org/obo/NCIT_C65200) (Thyroid Gland Follicular Carcinoma, Minimally Invasive), [NCIT:C27380](http://purl.obolibrary.org/obo/NCIT_C27380) (Thyroid Gland Adenocarcinoma), [NCIT:C3628](http://purl.obolibrary.org/obo/NCIT_C3628) (Benign Thyroid Gland Neoplasm), [NCIT:C7906](http://purl.obolibrary.org/obo/NCIT_C7906) (Thyroid Gland Undifferentiated Carcinoma, Osteoclastic Variant), [NCIT:C7509](http://purl.obolibrary.org/obo/NCIT_C7509) (Metastatic Malignant Neoplasm in the Thyroid Gland), [NCIT:C35558](http://purl.obolibrary.org/obo/NCIT_C35558) (Tall Cell Variant Thyroid Gland Papillary Carcinoma), [NCIT:C7908](http://purl.obolibrary.org/obo/NCIT_C7908) (Recurrent Thyroid Gland Carcinoma), [NCIT:C118827](http://purl.obolibrary.org/obo/NCIT_C118827) (Childhood Thyroid Gland Carcinoma), [NCIT:C3878](http://purl.obolibrary.org/obo/NCIT_C3878) (Thyroid Gland Undifferentiated (Anaplastic) Carcinoma), [NCIT:C46101](http://purl.obolibrary.org/obo/NCIT_C46101) (Neoplastic C-Cell Hyperplasia), [NCIT:C46100](http://purl.obolibrary.org/obo/NCIT_C46100) (C-Cell Hyperplasia), [NCIT:C123904](http://purl.obolibrary.org/obo/NCIT_C123904) (Childhood Thyroid Gland Follicular Carcinoma), [NCIT:C123905](http://purl.obolibrary.org/obo/NCIT_C123905) (Childhood Thyroid Gland Medullary Carcinoma), [NCIT:C46105](http://purl.obolibrary.org/obo/NCIT_C46105) (Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation), [NCIT:C46104](http://purl.obolibrary.org/obo/NCIT_C46104) (Thyroid Gland Mixed Medullary and Follicular Cell Carcinoma), [NCIT:C7510](http://purl.obolibrary.org/obo/NCIT_C7510) (Malignant Thyroid Gland Neoplasm), [NCIT:C7153](http://purl.obolibrary.org/obo/NCIT_C7153) (Differentiated Thyroid Gland Carcinoma), [NCIT:C46106](http://purl.obolibrary.org/obo/NCIT_C46106) (Thyroid Gland Carcinoma Showing Thymus-Like Differentiation), [NCIT:C123903](http://purl.obolibrary.org/obo/NCIT_C123903) (Childhood Thyroid Gland Papillary Carcinoma), [NCIT:C87545](http://purl.obolibrary.org/obo/NCIT_C87545) (Stage III Differentiated Thyroid Gland Carcinoma), [NCIT:C87543](http://purl.obolibrary.org/obo/NCIT_C87543) (Stage I Differentiated Thyroid Gland Carcinoma), [NCIT:C87544](http://purl.obolibrary.org/obo/NCIT_C87544) (Stage II Differentiated Thyroid Gland Carcinoma), [NCIT:C3879](http://purl.obolibrary.org/obo/NCIT_C3879) (Thyroid Gland Medullary Carcinoma), [NCIT:C46111](http://purl.obolibrary.org/obo/NCIT_C46111) (Thyroid Gland Follicular Adenoma with Papillary Hyperplasia), [NCIT:C5265](http://purl.obolibrary.org/obo/NCIT_C5265) (Thyroid Gland Lymphoma), [NCIT:C46118](http://purl.obolibrary.org/obo/NCIT_C46118) (Thyroid Gland Lipoadenoma), [NCIT:C8054](http://purl.obolibrary.org/obo/NCIT_C8054) (Thyroid Gland Follicular Carcinoma), [NCIT:C38762](http://purl.obolibrary.org/obo/NCIT_C38762) (Thyroid Gland Mucoepidermoid Carcinoma), [NCIT:C6040](http://purl.obolibrary.org/obo/NCIT_C6040) (Poorly Differentiated Thyroid Gland Carcinoma), [NCIT:C4815](http://purl.obolibrary.org/obo/NCIT_C4815) (Thyroid Gland Carcinoma), [NCIT:C6846](http://purl.obolibrary.org/obo/NCIT_C6846) (Thyroid Gland Hyalinizing Trabecular Tumor), [NCIT:C26893](http://purl.obolibrary.org/obo/NCIT_C26893) (Thyroid Gland Disorder), [NCIT:C3415](http://purl.obolibrary.org/obo/NCIT_C3415) (Thyroid Gland Nodule), [NCIT:C3414](http://purl.obolibrary.org/obo/NCIT_C3414) (Thyroid Gland Neoplasm), [NCIT:C46125](http://purl.obolibrary.org/obo/NCIT_C46125) (Thyroid Gland Paraganglioma), [NCIT:C6046](http://purl.obolibrary.org/obo/NCIT_C6046) (Thyroid Gland Diffuse Large B-Cell Lymphoma), [NCIT:C46004](http://purl.obolibrary.org/obo/NCIT_C46004) (Thyroid Gland Papillary Microcarcinoma), [NCIT:C46124](http://purl.obolibrary.org/obo/NCIT_C46124) (Thyroid Gland Teratoma), [NCIT:C133193](http://purl.obolibrary.org/obo/NCIT_C133193) (Metastatic Thyroid Gland Carcinoma), [NCIT:C46008](http://purl.obolibrary.org/obo/NCIT_C46008) (Thyroid Gland Squamous Cell Carcinoma), [NCIT:C6041](http://purl.obolibrary.org/obo/NCIT_C6041) (Thyroid Gland Sarcoma), [NCIT:C6044](http://purl.obolibrary.org/obo/NCIT_C6044) (Thyroid Gland Non-Hodgkin Lymphoma), [NCIT:C6043](http://purl.obolibrary.org/obo/NCIT_C6043) (Thyroid Gland Angiosarcoma), [NCIT:C9086](http://purl.obolibrary.org/obo/NCIT_C9086) (Stage IV Thyroid Gland Follicular Carcinoma), [NCIT:C9084](http://purl.obolibrary.org/obo/NCIT_C9084) (Stage I Thyroid Gland Follicular Carcinoma), [NCIT:C9085](http://purl.obolibrary.org/obo/NCIT_C9085) (Stage II Thyroid Gland Follicular Carcinoma), [NCIT:C9082](http://purl.obolibrary.org/obo/NCIT_C9082) (Stage II Thyroid Gland Papillary Carcinoma), [NCIT:C9083](http://purl.obolibrary.org/obo/NCIT_C9083) (Stage IV Thyroid Gland Papillary Carcinoma), [NCIT:C126598](http://purl.obolibrary.org/obo/NCIT_C126598) (Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features), [NCIT:C9081](http://purl.obolibrary.org/obo/NCIT_C9081) (Stage I Thyroid Gland Papillary Carcinoma), [NCIT:C37304](http://purl.obolibrary.org/obo/NCIT_C37304) (Multicentric Thyroid Gland Papillary Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C26893](http://purl.obolibrary.org/obo/NCIT_C26893) (Thyroid Gland Disorder) 99.24%
- [NCIT:C3414](http://purl.obolibrary.org/obo/NCIT_C3414) (Thyroid Gland Neoplasm) 96.97%
- [NCIT:C7510](http://purl.obolibrary.org/obo/NCIT_C7510) (Malignant Thyroid Gland Neoplasm) 89.39%
- [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) and [NCIT:C7510](http://purl.obolibrary.org/obo/NCIT_C7510) (Malignant Thyroid Gland Neoplasm) 86.36%
- [NCIT:C4815](http://purl.obolibrary.org/obo/NCIT_C4815) (Thyroid Gland Carcinoma) 83.33%
- [NCIT:C6077](http://purl.obolibrary.org/obo/NCIT_C6077) (Neck Carcinoma) and [NCIT:C7510](http://purl.obolibrary.org/obo/NCIT_C7510) (Malignant Thyroid Gland Neoplasm) 83.33%
- [NCIT:C3709](http://purl.obolibrary.org/obo/NCIT_C3709) (Epithelial Neoplasm) and [NCIT:C7510](http://purl.obolibrary.org/obo/NCIT_C7510) (Malignant Thyroid Gland Neoplasm) 83.33%
- [NCIT:C35850](http://purl.obolibrary.org/obo/NCIT_C35850) (Head and Neck Carcinoma) and [NCIT:C7510](http://purl.obolibrary.org/obo/NCIT_C7510) (Malignant Thyroid Gland Neoplasm) 83.33%
- [NCIT:C2916](http://purl.obolibrary.org/obo/NCIT_C2916) (Carcinoma) and [NCIT:C7510](http://purl.obolibrary.org/obo/NCIT_C7510) (Malignant Thyroid Gland Neoplasm) 83.33%
- [NCIT:C3575](http://purl.obolibrary.org/obo/NCIT_C3575) (Malignant Endocrine Neoplasm) and [NCIT:C7510](http://purl.obolibrary.org/obo/NCIT_C7510) (Malignant Thyroid Gland Neoplasm) 75.76%
- [NCIT:C3575](http://purl.obolibrary.org/obo/NCIT_C3575) (Malignant Endocrine Neoplasm) and [NCIT:C4815](http://purl.obolibrary.org/obo/NCIT_C4815) (Thyroid Gland Carcinoma) 75.76%
- [NCIT:C3010](http://purl.obolibrary.org/obo/NCIT_C3010) (Endocrine Neoplasm) and [NCIT:C7510](http://purl.obolibrary.org/obo/NCIT_C7510) (Malignant Thyroid Gland Neoplasm) 75.76%
- [NCIT:C3010](http://purl.obolibrary.org/obo/NCIT_C3010) (Endocrine Neoplasm) and [NCIT:C4815](http://purl.obolibrary.org/obo/NCIT_C4815) (Thyroid Gland Carcinoma) 75.76%
- [NCIT:C3009](http://purl.obolibrary.org/obo/NCIT_C3009) (Endocrine System Disorder) and [NCIT:C7510](http://purl.obolibrary.org/obo/NCIT_C7510) (Malignant Thyroid Gland Neoplasm) 75.76%
- [NCIT:C3009](http://purl.obolibrary.org/obo/NCIT_C3009) (Endocrine System Disorder) and [NCIT:C4815](http://purl.obolibrary.org/obo/NCIT_C4815) (Thyroid Gland Carcinoma) 75.76%


